NanoViricides (NNVC) Stock: Buy, Sell, or Hold?
$1.35
-0.03 (-2.17%)
âŧ
5d:
+4.65%
30d:
+3.05%
90d:
-2.17%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
36/100
Position
FAIR
30-Day Fair Range
$1.32 â $1.44
Position: FAIR
Forward P/E & Valuation
-3.9x
Next 12M consensus est.
Wall Street Target
$6.00
+344.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.26 / $1.47
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: NNVC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When NNVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NNVC is currently trading at $1.35, which is considered fair relative to its 30-day fair value range of $1.32 to $1.44.
Technical Outlook: Technically, NNVC is in a downtrend. Immediate support is located at $1.26, while resistance sits at $1.47.
Market Sentiment: NNVC scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+344.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NNVC is in a downtrend. Immediate support is located at $1.26, while resistance sits at $1.47.
Market Sentiment: NNVC scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+344.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.32 -
$1.44
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
Trading Range & Key Levels
30-Day Trading Range
$1.32 -
$1.44
Current vs Trading Range
FAIR
Support Level
$1.26
Resistance Level
$1.47
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 344.4% below Wall St target ($6.00)
- WARNING: Composite score 36/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.86
Wall Street Target
$6.00
(+344.4%)
Share NNVC Analysis
Share this live NNVC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NNVC)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates $NNVC on StockTwits with one trader expressing concern about the company.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:46 AM ET
Data refreshes hourly during market hours. Next update: 5:46 AM
Data refreshes hourly during market hours. Next update: 5:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NNVC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 39 SELL |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
IDYA
Ideaya Biosciences Inc |
STRONG BUY
16 analysts |
$51 | 60 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NNVC Research Pages